Immunotherapeutic Biologic Agents to Treat Autoinflammatory Diseases
-
Published:2017-04-26
Issue:
Volume:
Page:
-
ISSN:
-
Container-title:Immunotherapy - Myths, Reality, Ideas, Future
-
language:
-
Short-container-title:
Author:
Ostrov Barbara E.
Reference75 articles.
1. Stoffels M, Kastner DL: Old dogs, new tricks: monogenic autoinflammatory disease unleashed. Annu Rev Genom Hum Genet. 2016; 17:18.1–28
2. Volpi S, Picco P, Caorsi R, et al: Type 1 interferonopathies in pediatric rheumatology. Pediatric Rheumatol. 2016; 14:35–47
3. Hoffman HM, Broderick L: The role of the inflammasome in patients with autoinflammatory diseases. J Allergy Clin Immunol. 2016; 138:3–14
4. Canna SW, de Jesus AA, Gouni S, et al: An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent MAS. Nat Genet. 2014; 46:1140–6
5. Martinon F, Burns K, Tschopp J: The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of pro-IL-beta. Mol Cell. 2002; 10:417–26